Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Kinase inhibitors

Narrowing down the real targets

Nature Chemical Biology volume 6, pages 249–250 (2010)Cite this article

Subjects

Many kinase inhibitors for cancer therapy are rather nonselective, and their cellular mechanisms of action are incompletely understood. A nested chemical proteomics and chemical genetics strategy reveals which cellular targets of the clinical kinase inhibitor dasatinib functionally relate to its anti-oncogenic activity.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Nested chemical proteomics and genetics strategy for kinase inhibitor analysis.

References

  1. Karaman, M.W. et al. Nat. Biotechnol. 26, 127–132 (2008).

    Article  CAS  Google Scholar 

  2. Rix, U. & Superti-Furga, G. Nat. Chem. Biol. 5, 616–624 (2009).

    Article  CAS  Google Scholar 

  3. Li, J. et al. Nat. Chem. Biol. 6, 291–299 (2010).

    Article  CAS  Google Scholar 

  4. Huang, F. et al. Cancer Res. 67, 2226–2238 (2007).

    Article  CAS  Google Scholar 

  5. Sos, M.L. et al. J. Clin. Invest. 119, 1727–1740 (2009).

    Article  CAS  Google Scholar 

  6. Blencke, S. et al. Chem. Biol. 11, 691–701 (2004).

    Article  CAS  Google Scholar 

  7. Hantschel, O. et al. Proc. Natl. Acad. Sci. USA 104, 13283–13288 (2007).

    Article  CAS  Google Scholar 

  8. Haura, E.B. et al. J. Clin. Oncol. published online, doi:10.1200/JCO.2009.25.4029 (8 February 2010).

  9. Downward, J. Nature 462, 44–45 (2009).

    Article  CAS  Google Scholar 

  10. Pan, C., Olsen, J.V., Daub, H. & Mann, M. Mol. Cell. Proteomics 8, 2796–2808 (2009).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Biology, Henrik Daub is in the Project Group Cell Signaling, Max Planck Institute of Biochemistry, Martinsried, Germany.,

    Henrik Daub

Authors
  1. Henrik Daub
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Henrik Daub.

Ethics declarations

Competing interests

H.D. is a shareholder of and has a consultancy agreement with Kinaxo Biotechnologies GmbH.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Daub, H. Narrowing down the real targets. Nat Chem Biol 6, 249–250 (2010). https://doi.org/10.1038/nchembio.336

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nchembio.336

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research